What is he best known for?
The fields of study he is best known for:
His primary areas of study are Cell biology, Cancer research, Molecular biology, Signal transduction and Kinase.
Wang Min studies Cell biology, focusing on Mitochondrion in particular.
His Cancer research research is multidisciplinary, incorporating elements of Tumor progression, Metastasis, Stem cell and Prostate cancer.
His Molecular biology research incorporates themes from Transcription factor, Transcription and Ifn gamma.
His Kinase study incorporates themes from Protein kinase B, Phosphorylation and PI3K/AKT/mTOR pathway.
Wang Min focuses mostly in the field of Endothelium, narrowing it down to matters related to Angiogenesis and, in some cases, Progenitor cell, Mural cell and Pathology.
His most cited work include:
- The imprinted H19 lncRNA antagonizes let-7 microRNAs. (712 citations)
- Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth (499 citations)
- Thioredoxin-2 Inhibits Mitochondria-Located ASK1-Mediated Apoptosis in a JNK-Independent Manner (212 citations)
What are the main themes of his work throughout his whole career to date?
Wang Min mostly deals with Cell biology, Cancer research, Angiogenesis, Signal transduction and Endothelial stem cell.
His Cell biology study combines topics in areas such as Thioredoxin and Endothelium.
His Cancer research research includes elements of Tumor necrosis factor alpha, Cell growth, Tyrosine kinase, Receptor and Metastasis.
In his research, Inflammation is intimately related to Cytokine, which falls under the overarching field of Tumor necrosis factor alpha.
His study in Angiogenesis is interdisciplinary in nature, drawing from both Kinase insert domain receptor, Immunology and Lymphangiogenesis.
The concepts of his Endothelial stem cell study are interwoven with issues in Vascular endothelial growth factor B, Endocrinology, Retinal and Internal medicine.
He most often published in these fields:
- Cell biology (67.66%)
- Cancer research (31.74%)
- Angiogenesis (23.95%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (67.66%)
- Inflammation (19.16%)
- Cancer research (31.74%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cell biology, Inflammation, Cancer research, Mitochondrion and SUMO protein.
His Cell biology research is mostly focused on the topic Stem cell.
His work is dedicated to discovering how Inflammation, Oxidative stress are connected with Neointima and Neointimal hyperplasia and other disciplines.
He has researched Cancer research in several fields, including Spheroid, Cell, Ovarian cancer and Metastasis.
His work carried out in the field of Mitochondrion brings together such families of science as Reactive oxygen species, Proinflammatory cytokine, Thioredoxin, Vascular homeostasis and Mitophagy.
In his study, Pathological Angiogenesis and VEGF receptors is strongly linked to Intracellular, which falls under the umbrella field of SUMO protein.
Between 2017 and 2021, his most popular works were:
- Mitochondria, Oxidative Stress and Innate Immunity. (88 citations)
- Mitochondria, Oxidative Stress and Innate Immunity. (88 citations)
- Dynamic m 6 A mRNA methylation reveals the role of METTL3-m 6 A-CDCP1 signaling axis in chemical carcinogenesis (53 citations)
In his most recent research, the most cited papers focused on:
Wang Min focuses on Cell biology, Cancer research, Inflammasome, Inflammation and Reactive oxygen species.
His work in the fields of Cell biology, such as Intracellular, overlaps with other areas such as Lysine.
He interconnects Carcinogenesis, Cell, Methylation and Oncogene in the investigation of issues within Cancer research.
The various areas that Wang Min examines in his Inflammasome study include Oxidative stress, Thioredoxin, Metabolic pathway, Innate immune system and Mitochondrion.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
